Prof. Simon W. Rabkin E-Mail
Professor of Medicine, University of British Columbia; Cardiology Staff, Vancouver Hospital, Vancouver, Canada
Hypertension remains an important factor leading to many conditions including heart failure, chronic kidney disease, stroke, aortic aneurysms and dementia. The objective of this volume is to focus on areas that have advanced our knowledge and will guide clinicians and scientists to future advances in the field. The contributions in this issue should improve our knowledge on the detection/diagnosis of hypertension and its consequences, improve our understanding of the pathophysiologic linkages in hypertension and guide us to better prevention, management and control in order to lessen the burden of hypertension associated diseases. There’s still much to learn about how hypertension leads to its devastating effects on the heart, kidney, arteries, brain and other organs. This issue will be inclusive and encompass all important areas of recent advances spanned the range from genetics, epigenetics, immunology, micro RNA, vascular and organ structural changes, signal transduction pathways, neurohormonal activation and inhibition, as well as clinical advances and insights. Advances in potential therapeutic areas will also be included. This issue on Recent Advances in Hypertension will be a summary of recent advances in the field and also will be a guide for clinicians and scientists on how we should proceed to better control or eliminate hypertension and its adverse consequences. non-coding RNA, gut microbiota, ageing, uremic toxins, biological activity, medical use, pharmacological interactions.